Jonkers, I J <br/><br/>
Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia.  [electronic resource] 

 -  Journal of hypertension  Apr 2001 
 - 749-55 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0263-6352 
<br/><br/><label>Standard No.: </label>10.1097/00004872-200104000-00012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorption<br/>Adult<br/>Bezafibrate--therapeutic use<br/>Blood Pressure--drug effects<br/>Cyclic GMP--blood<br/>Double-Blind Method<br/>Fatty Acids, Nonesterified--blood<br/>Female<br/>Heart Rate--drug effects<br/>Hemodynamics--drug effects<br/>Humans<br/>Hypertriglyceridemia--drug therapy<br/>Hypolipidemic Agents--therapeutic use<br/>Insulin--blood<br/>Kidney--metabolism<br/>Lipids--blood<br/>Male<br/>Middle Aged<br/>Sodium--metabolism<br/>Sympathetic Nervous System--physiopathology